Single-nucleus RNA sequencing and network pharmacology reveal the mediation of fisetin on neuroinflammation in Alzheimer's disease
- 5 April 2025
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 141, 156724
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82460267)
- Natural Science Foundation of Guangxi Province
- Guangxi Medical University
This publication has 70 references indexed in Scilit:
- Complex heatmap visualizationiMeta, 2022
- Platelet-derived growth factor signalling in neurovascular function and diseaseThe International Journal of Biochemistry & Cell Biology, 2022
- Molecular dynamics and structure-based virtual screening and identification of natural compounds as Wnt signaling modulators: possible therapeutics for Alzheimer’s diseaseMolecular Diversity, 2022
- Biomarkers used in Alzheimer’s disease diagnosis, treatment, and preventionAgeing Research Reviews, 2022
- Inference of Gene Regulatory Network from Single-Cell Transcriptomic Data Using pySCENIC2021
- Microglial NMDA receptors drive pro‐inflammatory responses via PARP‐1/TRMP2 signalingGlia, 2020
- RCSB Protein Data Bank: Enabling biomedical research and drug discoveryProtein Science, 2019
- Fisetin inhibits IL-1β-induced inflammatory response in human osteoarthritis chondrocytes through activating SIRT1 and attenuates the progression of osteoarthritis in miceInternational Immunopharmacology, 2017
- Fisetin and Its Role in Chronic Diseases2016
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009